iBio, Inc. (IBIO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q3-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-Q | Q2-2026 | 8-K (2026-02-10) · 99.1 | ||
| 10-Q/A | Q1-2026 | |||
| 10-Q | Q1-2026 | 8-K (2025-11-12) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-09-05) · 99.1 | 8-K (2025-08-18) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-05-02) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-02-10) · 99.1 | 8-K (2024-11-25) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2024-11-12) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2024-09-20) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | 8-K (2023-09-27) · 99.1 | 8-K (2023-09-21) · 99.1 | 8-K (2023-08-07) | ||
| 10-Q/A | Q2-2023 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Equity | — |
|
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders' Equity (P) | — |
|
| Notes | ||
| Accrued Expenses | — |
|
| Basis of Presentation | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Discontinued Operations | ||
| Earnings (loss) Per Common Share | ||
| Employee 401(k) Plan | ||
| Finance Lease Obligations | ||
| Finance Lease Rou Assets | ||
| Financial Instruments and Fair Value Measurements | ||
| Fixed Assets | ||
| Fraunhofer Settlement | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| Investments In Debt Securities | ||
| Nature of Business | ||
| Operating Lease Obligations | ||
| Operating Lease Rou Assets | ||
| Pay Vs Performance Disclosure | ||
| Promissory Note Receivable | ||
| Share-based Compensation | ||
| Significant Transactions | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||